<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20241005021335&amp;utm_campaign=pubmed-2&amp;utm_source=Chrome&amp;v=2.18.0.post9+e462414&amp;utm_medium=rss
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20241005021335&amp;utm_campaign=pubmed-2&amp;utm_source=Chrome&amp;v=2.18.0.post9+e462414&amp;utm_medium=rss" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Sat, 05 Oct 2024 06:13:36 +0000</lastbuilddate>
<pubDate>Fri, 04 Oct 2024 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>Correction</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39365640/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241005021335&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 4:ehae701. doi: 10.1093/eurheartj/ehae701. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39365640/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241005021335&v=2.18.0.post9+e462414">39365640</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae701>10.1093/eurheartj/ehae701</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39365640</guid>
<pubDate>Fri, 04 Oct 2024 06:00:00 -0400</pubDate>
<dc:date>2024-10-04</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Correction</dc:title>
<dc:identifier>pmid:39365640</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae701</dc:identifier>
</item>
<item>
<title>A similar severe fibrosis pattern in a monozygotic twin pair with the TRIM63 variant manifesting as hypertrophic cardiomyopathy</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39365612/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241005021335&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 4:ehae607. doi: 10.1093/eurheartj/ehae607. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39365612/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241005021335&v=2.18.0.post9+e462414">39365612</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae607>10.1093/eurheartj/ehae607</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39365612</guid>
<pubDate>Fri, 04 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Lutong Pu</dc:creator>
<dc:creator>Jie Wang</dc:creator>
<dc:creator>Yucheng Chen</dc:creator>
<dc:date>2024-10-04</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>A similar severe fibrosis pattern in a monozygotic twin pair with the TRIM63 variant manifesting as hypertrophic cardiomyopathy</dc:title>
<dc:identifier>pmid:39365612</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae607</dc:identifier>
</item>
<item>
<title>The Apple May Fall Far From the Family Tree in Hypertrophic Cardiomyopathy</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39365228/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241005021335&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Sep 25:S0735-1097(24)08450-X. doi: 10.1016/j.jacc.2024.08.066. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39365228/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241005021335&v=2.18.0.post9+e462414">39365228</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.08.066>10.1016/j.jacc.2024.08.066</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39365228</guid>
<pubDate>Fri, 04 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Nosheen Reza</dc:creator>
<dc:date>2024-10-04</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>The Apple May Fall Far From the Family Tree in Hypertrophic Cardiomyopathy</dc:title>
<dc:identifier>pmid:39365228</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.08.066</dc:identifier>
</item>
<item>
<title>Prevalence and Impact of Recurrent Rejection on Pediatric Heart Transplant Recipients: A PHTS Multi-Institutional Analysis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39365227/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241005021335&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Although prevalence of RR has decreased, children experiencing RR are at greatly increased risk for losing their graft, particularly those who have recurrent mixed or antibody-mediated rejection.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Sep 25:S0735-1097(24)08160-9. doi: 10.1016/j.jacc.2024.08.010. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Studies evaluating the prevalence and impact of recurrent rejection (RR) in pediatric heart transplant (HT) are sparse.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: The purpose of this study was to describe prevalence and impact of RR on cardiac allograft vasculopathy (CAV) and graft loss after pediatric HT.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Data on HT from January 1, 2000, to June 30, 2020, in the Pediatric Heart Transplant Society database were included. Freedom from RR (≥2 rejection episodes) was compared by era (early: 2000-2009; current: 2010-2020). Outcomes for children experiencing RR were compared with those experiencing 0 or 1 rejection episodes and by type of RR (antibody-mediated rejection [AMR], acute cellular rejection [ACR], mixed [ACR/AMR]).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Of 6,342 HT recipients, 1,035 (17%) experienced RR. In the current era, pediatric HT recipients were less likely to experience RR (P &lt; 0.001). Freedom from CAV was similar for those experiencing RR to those experiencing 0 or 1 episode (96.6% vs 95.3% vs 96.6%); and similar regardless of the type of RR (AMR, ACR, or mixed) (65.5% vs 82.9% vs 100%) (P >; 0.05). Freedom from graft loss was significantly lower for those experiencing RR to those experiencing 0 or 1 episode (56.3% vs 72.3% vs 82.3%) and lower for those experiencing recurrent mixed rejection or recurrent AMR compared with those experiencing recurrent ACR (65.3% vs 50% vs 81.8%). Black children experiencing RR subsequently had lower freedom from CAV and graft loss than White children (P &lt; 0.05 for all).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Although prevalence of RR has decreased, children experiencing RR are at greatly increased risk for losing their graft, particularly those who have recurrent mixed or antibody-mediated rejection.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39365227/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241005021335&v=2.18.0.post9+e462414">39365227</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.08.010>10.1016/j.jacc.2024.08.010</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39365227</guid>
<pubDate>Fri, 04 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Shahnawaz Amdani</dc:creator>
<dc:creator>James K Kirklin</dc:creator>
<dc:creator>Ryan Cantor</dc:creator>
<dc:creator>Devin Koehl</dc:creator>
<dc:creator>Ashwin Lal</dc:creator>
<dc:creator>Peter Chau</dc:creator>
<dc:creator>Valerie Curren</dc:creator>
<dc:creator>Jonathan B Edelson</dc:creator>
<dc:creator>John J Parent</dc:creator>
<dc:creator>Hannah Victor</dc:creator>
<dc:creator>Ali Burnette</dc:creator>
<dc:creator>Jacqueline M Lamour</dc:creator>
<dc:date>2024-10-04</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Prevalence and Impact of Recurrent Rejection on Pediatric Heart Transplant Recipients: A PHTS Multi-Institutional Analysis</dc:title>
<dc:identifier>pmid:39365227</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.08.010</dc:identifier>
</item>
<item>
<title>Comprehensive Proteomic Profiling of Human Myocardium Reveals Signaling Pathways Dysregulated in Hypertrophic Cardiomyopathy</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39365226/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241005021335&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: The present study represents the most comprehensive (>;7,000 proteins) and largest-scale (n = 99 HCM cases) proteomic profiling of human HCM myocardium to date. Proteomic profiling and confirmatory transcriptomic profiling elucidate dysregulation of both newly recognized (eg, Ras-mitogen-activated protein kinase) and known pathways associated with pathogenesis and progression to severe forms of HCM.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Sep 25:S0735-1097(24)08159-2. doi: 10.1016/j.jacc.2024.07.043. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiac disease. Signaling pathways that link genetic sequence variants to clinically overt HCM and progression to severe forms of HCM remain unknown.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: The purpose of this study was to identify signaling pathways that are differentially regulated in HCM, using proteomic profiling of human myocardium, confirmed with transcriptomic profiling.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: In this multicenter case-control study, myocardial samples were obtained from cases with HCM and control subjects with nonfailing hearts. Proteomic profiling of 7,289 proteins from myocardial samples was performed using the SomaScan assay (SomaLogic). Pathway analysis of differentially expressed proteins was performed, using a false discovery rate &lt;0.05. Pathway analysis of proteins whose concentrations correlated with clinical indicators of severe HCM (eg, reduced left ventricular ejection fraction, atrial fibrillation, and ventricular tachyarrhythmias) was also executed. Confirmatory analysis of differentially expressed genes was performed using myocardial transcriptomic profiling.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The study included 99 HCM cases and 15 control subjects. Pathway analysis of differentially expressed proteins revealed dysregulation of the Ras-mitogen-activated protein kinase, ubiquitin-mediated proteolysis, angiogenesis-related (eg, hypoxia-inducible factor-1, vascular endothelial growth factor), and Hippo pathways. Pathways known to be dysregulated in HCM, including metabolic, inflammatory, and extracellular matrix pathways, were also dysregulated. Pathway analysis of proteins associated with clinical indicators of severe HCM and of differentially expressed genes supported these findings.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: The present study represents the most comprehensive (>;7,000 proteins) and largest-scale (n = 99 HCM cases) proteomic profiling of human HCM myocardium to date. Proteomic profiling and confirmatory transcriptomic profiling elucidate dysregulation of both newly recognized (eg, Ras-mitogen-activated protein kinase) and known pathways associated with pathogenesis and progression to severe forms of HCM.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39365226/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241005021335&v=2.18.0.post9+e462414">39365226</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.07.043>10.1016/j.jacc.2024.07.043</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39365226</guid>
<pubDate>Fri, 04 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Heidi S Lumish</dc:creator>
<dc:creator>Mark V Sherrid</dc:creator>
<dc:creator>Paul M L Janssen</dc:creator>
<dc:creator>Giovanni Ferrari</dc:creator>
<dc:creator>Kohei Hasegawa</dc:creator>
<dc:creator>Estibaliz Castillero</dc:creator>
<dc:creator>Elizabeth Adlestein</dc:creator>
<dc:creator>Daniel G Swistel</dc:creator>
<dc:creator>Veli K Topkara</dc:creator>
<dc:creator>Mathew S Maurer</dc:creator>
<dc:creator>Muredach P Reilly</dc:creator>
<dc:creator>Yuichi J Shimada</dc:creator>
<dc:date>2024-10-04</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Comprehensive Proteomic Profiling of Human Myocardium Reveals Signaling Pathways Dysregulated in Hypertrophic Cardiomyopathy</dc:title>
<dc:identifier>pmid:39365226</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.07.043</dc:identifier>
</item>
<item>
<title>Proteomic Profiling: The Key to Unlocking the Complexities of Hypertrophic Cardiomyopathy</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39365225/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241005021335&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Sep 25:S0735-1097(24)08461-4. doi: 10.1016/j.jacc.2024.08.071. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39365225/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241005021335&v=2.18.0.post9+e462414">39365225</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.08.071>10.1016/j.jacc.2024.08.071</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39365225</guid>
<pubDate>Fri, 04 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Sakthivel Sadayappan</dc:creator>
<dc:date>2024-10-04</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Proteomic Profiling: The Key to Unlocking the Complexities of Hypertrophic Cardiomyopathy</dc:title>
<dc:identifier>pmid:39365225</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.08.071</dc:identifier>
</item>
<item>
<title>Family Screening in Hypertrophic Cardiomyopathy: Identification of Relatives With Low Yield From Systematic Follow-Up</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39365224/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241005021335&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: In HCM, the diagnostic yield of a single screening visit was 1 in 4, and the additional yield during 7 years of follow-up was 4%. Gene carriers and relatives from gene-elusive families with a baseline MWT of ≥10 mm were at the highest risk of developing HCM during follow-up. These findings may inform future recommendations on the management of relatives of HCM patients.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Sep 25:S0735-1097(24)08161-0. doi: 10.1016/j.jacc.2024.08.011. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Hypertrophic cardiomyopathy (HCM) is a common inherited cardiac disease, and clinical and genetic family screening is recommended by guidelines.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: This study sought to investigate the diagnostic yield of screening relatives of HCM patients and identify predictive factors for HCM development during long-term follow-up in relatives from gene-elusive families.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: This was a retrospective cohort study of families screened at clinics for inherited cardiomyopathies in Eastern Denmark, from 2006 to 2023.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: We included 1,230 relatives (55% female; age: 42 ± 17 years) from 531 families. The combined clinical and genetic yield at baseline was 26% (n = 321). After 7 years (mean) of follow-up (6,762 person-years), 43 (4%) additional relatives developed HCM. The strongest predictors of developing HCM were carrying a likely pathogenic/pathogenic variant (HR: 4.58; 95% CI: 2.50-8.40; P &lt; 0.001) and larger left ventricular maximum wall thickness (MWT) (HR: 2.21 per mm; 95% CI: 1.76-2.77 per mm; P &lt; 0.001). In gene-elusive families, we found that an MWT of ≥10 mm represented the optimal classification threshold for developing HCM (area under the curve: 0.80), with only 2 (0.4%) relatives from gene-elusive families with an MWT of &lt;10 mm developing HCM during follow-up.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: In HCM, the diagnostic yield of a single screening visit was 1 in 4, and the additional yield during 7 years of follow-up was 4%. Gene carriers and relatives from gene-elusive families with a baseline MWT of ≥10 mm were at the highest risk of developing HCM during follow-up. These findings may inform future recommendations on the management of relatives of HCM patients.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39365224/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241005021335&v=2.18.0.post9+e462414">39365224</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.08.011>10.1016/j.jacc.2024.08.011</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39365224</guid>
<pubDate>Fri, 04 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Elvira Silajdzija</dc:creator>
<dc:creator>Christoffer Rasmus Vissing</dc:creator>
<dc:creator>Emma Basse Christensen</dc:creator>
<dc:creator>Helen Lamiokor Mills</dc:creator>
<dc:creator>Thilde Olivia Kock</dc:creator>
<dc:creator>Lars Juel Andersen</dc:creator>
<dc:creator>Martin Snoer</dc:creator>
<dc:creator>Jens Jakob Thune</dc:creator>
<dc:creator>Emil Daniel Bartels</dc:creator>
<dc:creator>Anna Axelsson Raja</dc:creator>
<dc:creator>Alex Hørby Christensen</dc:creator>
<dc:creator>Henning Bundgaard</dc:creator>
<dc:date>2024-10-04</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Family Screening in Hypertrophic Cardiomyopathy: Identification of Relatives With Low Yield From Systematic Follow-Up</dc:title>
<dc:identifier>pmid:39365224</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.08.011</dc:identifier>
</item>
<item>
<title>Effect of Cholesterol-Lowering Variants in ANGPTL3 and APOB Genes on Liver Disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39365223/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241005021335&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Sep 25:S0735-1097(24)08165-8. doi: 10.1016/j.jacc.2024.08.013. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39365223/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241005021335&v=2.18.0.post9+e462414">39365223</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.08.013>10.1016/j.jacc.2024.08.013</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39365223</guid>
<pubDate>Fri, 04 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Alessia Di Costanzo</dc:creator>
<dc:creator>Ilaria Pirona</dc:creator>
<dc:creator>Silvia Buonaiuto</dc:creator>
<dc:creator>Laura D'Erasmo</dc:creator>
<dc:creator>Simone Bini</dc:creator>
<dc:creator>Daniele Tramontano</dc:creator>
<dc:creator>Stella Covino</dc:creator>
<dc:creator>Carlo Maiorca</dc:creator>
<dc:creator>Ilenia Minicocci</dc:creator>
<dc:creator>Marialuisa Sponziello</dc:creator>
<dc:creator>Francesco Baratta</dc:creator>
<dc:creator>Daniela Commodari</dc:creator>
<dc:creator>Vincenza Colonna</dc:creator>
<dc:creator>Allegra Via</dc:creator>
<dc:creator>Marcello Arca</dc:creator>
<dc:date>2024-10-04</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Effect of Cholesterol-Lowering Variants in ANGPTL3 and APOB Genes on Liver Disease</dc:title>
<dc:identifier>pmid:39365223</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.08.013</dc:identifier>
</item>
<item>
<title>Applying Clinical Risk Scores in Real-World Practice: The CHA&lt;sub>;2&lt;/sub>;DS&lt;sub>;2&lt;/sub>;-VASc Score in Atrial Fibrillation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39365222/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241005021335&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Sep 25:S0735-1097(24)08169-5. doi: 10.1016/j.jacc.2024.08.017. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39365222/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241005021335&v=2.18.0.post9+e462414">39365222</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.08.017>10.1016/j.jacc.2024.08.017</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39365222</guid>
<pubDate>Fri, 04 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Geoffrey D Barnes</dc:creator>
<dc:creator>Gregory Y H Lip</dc:creator>
<dc:date>2024-10-04</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Applying Clinical Risk Scores in Real-World Practice: The CHA&lt;sub>;2&lt;/sub>;DS&lt;sub>;2&lt;/sub>;-VASc Score in Atrial Fibrillation</dc:title>
<dc:identifier>pmid:39365222</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.08.017</dc:identifier>
</item>
<item>
<title>Hit Differently: Disparities Persist in Recurrent Rejection After Pediatric Heart Transplant</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39365221/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241005021335&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Sep 25:S0735-1097(24)08384-0. doi: 10.1016/j.jacc.2024.09.001. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39365221/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241005021335&v=2.18.0.post9+e462414">39365221</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.09.001>10.1016/j.jacc.2024.09.001</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39365221</guid>
<pubDate>Fri, 04 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Amanda D McCormick</dc:creator>
<dc:creator>David M Peng</dc:creator>
<dc:date>2024-10-04</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Hit Differently: Disparities Persist in Recurrent Rejection After Pediatric Heart Transplant</dc:title>
<dc:identifier>pmid:39365221</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.09.001</dc:identifier>
</item>
<item>
<title>Acute Alcohol Consumption and Arrhythmias in Young Adults: The MunichBREW II Study</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39363568/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241005021335&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: The study demonstrates the impact of binge drinking on heart rate alterations and increased atrial tachycardias during 'drinking period', and the occurrence of clinically relevant arrythmias during the 'recovery period', emphasizing the holiday heart syndrome as a health concern.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 4:ehae695. doi: 10.1093/eurheartj/ehae695. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: and aims: Acute excessive alcohol intake may cause the holiday heart syndrome, characterized by cardiac arrhythmias including atrial fibrillation. Since underlying data are scarce, the study aimed to prospectively investigate the temporal course of occurring cardiac arrhythmias following binge drinking in young adults.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: A total of 202 volunteers planning acute alcohol consumption with expected peak breath alcohol concentrations (BAC) of ≥1.2 g/kg were enrolled. The study comprised 48-hour electrocardiogram (ECG) monitoring covering baseline (hour 0), 'drinking period' (hours 1-5), 'recovery period' (hours 6-19), and two control periods corresponding to 24 hours after the 'drinking' and 'recovery periods', respectively. Acute alcohol intake was monitored by BAC measurements during the 'drinking period'. ECGs were analyzed for mean heart rate, atrial tachycardia, premature atrial complexes (PAC), premature ventricular complexes (PVC), and heart rate variability (HRV) measures.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Data revealed an increase in heart rate and an excess of atrial tachycardias with increasing alcohol intake. HRV analysis indicated an autonomic modulation with sympathetic activation during alcohol consumption and the subsequent 'recovery period', followed by parasympathetic predominance thereafter. PACs occurred significantly more frequently in the 'control periods', whereas PVCs were more frequent in the 'drinking period'. Ten participants experienced notable arrhythmic episodes, including atrial fibrillation and ventricular tachycardias, primarily during the 'recovery period'.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: The study demonstrates the impact of binge drinking on heart rate alterations and increased atrial tachycardias during 'drinking period', and the occurrence of clinically relevant arrythmias during the 'recovery period', emphasizing the holiday heart syndrome as a health concern.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39363568/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241005021335&v=2.18.0.post9+e462414">39363568</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae695>10.1093/eurheartj/ehae695</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39363568</guid>
<pubDate>Fri, 04 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Stefan Brunner</dc:creator>
<dc:creator>Christina Krewitz</dc:creator>
<dc:creator>Raphaela Winter</dc:creator>
<dc:creator>Aenne S von Falkenhausen</dc:creator>
<dc:creator>Anna Kern</dc:creator>
<dc:creator>Dorothee Brunner</dc:creator>
<dc:creator>Moritz F Sinner</dc:creator>
<dc:date>2024-10-04</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Acute Alcohol Consumption and Arrhythmias in Young Adults: The MunichBREW II Study</dc:title>
<dc:identifier>pmid:39363568</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae695</dc:identifier>
</item>
<item>
<title>Private information leakage from single-cell count matrices</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39362221/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241005021335&amp;v=2.18.0.post9+e462414
      <description>The increase in publicly available human single-cell datasets, encompassing millions of cells from many donors, has significantly enhanced our understanding of complex biological processes. However, the accessibility of these datasets raises significant privacy concerns. Due to the inherent noise in single-cell measurements and the scarcity of population-scale single-cell datasets, recent private information quantification studies have focused on bulk gene expression data sharing. To address...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Sep 27:S0092-8674(24)01030-4. doi: 10.1016/j.cell.2024.09.012. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The increase in publicly available human single-cell datasets, encompassing millions of cells from many donors, has significantly enhanced our understanding of complex biological processes. However, the accessibility of these datasets raises significant privacy concerns. Due to the inherent noise in single-cell measurements and the scarcity of population-scale single-cell datasets, recent private information quantification studies have focused on bulk gene expression data sharing. To address this gap, we demonstrate that individuals in single-cell gene expression datasets are vulnerable to linking attacks, where attackers can infer their sensitive phenotypic information using publicly available tissue or cell-type-specific expression quantitative trait loci (eQTLs) information. We further develop a method for genotype prediction and genotype-phenotype linking that remains effective without relying on eQTL information. We show that variants from one study can be exploited to uncover private information about individuals in another study.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39362221/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241005021335&v=2.18.0.post9+e462414">39362221</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.09.012>10.1016/j.cell.2024.09.012</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39362221</guid>
<pubDate>Thu, 03 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Conor R Walker</dc:creator>
<dc:creator>Xiaoting Li</dc:creator>
<dc:creator>Manav Chakravarthy</dc:creator>
<dc:creator>William Lounsbery-Scaife</dc:creator>
<dc:creator>Yoolim A Choi</dc:creator>
<dc:creator>Ritambhara Singh</dc:creator>
<dc:creator>Gamze Gürsoy</dc:creator>
<dc:date>2024-10-03</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Private information leakage from single-cell count matrices</dc:title>
<dc:identifier>pmid:39362221</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.09.012</dc:identifier>
</item>
<item>
<title>Optical coherence tomography for optimal stent implantation: what to check?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39361492/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241005021335&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 3:ehae626. doi: 10.1093/eurheartj/ehae626. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39361492/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241005021335&v=2.18.0.post9+e462414">39361492</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae626>10.1093/eurheartj/ehae626</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39361492</guid>
<pubDate>Thu, 03 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Enrico Romagnoli</dc:creator>
<dc:creator>Mattia Lunardi</dc:creator>
<dc:creator>Francesco Burzotta</dc:creator>
<dc:date>2024-10-03</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Optical coherence tomography for optimal stent implantation: what to check?</dc:title>
<dc:identifier>pmid:39361492</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae626</dc:identifier>
</item>
<item>
<title>Was the embroidery needle truly fractured by the heart?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39361490/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241005021335&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 3:ehae634. doi: 10.1093/eurheartj/ehae634. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39361490/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241005021335&v=2.18.0.post9+e462414">39361490</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae634>10.1093/eurheartj/ehae634</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39361490</guid>
<pubDate>Thu, 03 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Yao Hu</dc:creator>
<dc:creator>Yurong Guo</dc:creator>
<dc:creator>Fuling Huang</dc:creator>
<dc:date>2024-10-03</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Was the embroidery needle truly fractured by the heart?</dc:title>
<dc:identifier>pmid:39361490</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae634</dc:identifier>
</item>
<item>
<title>Is lower birthweight truly causal for increased cardiovascular risk?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39361488/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241005021335&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 3:ehae509. doi: 10.1093/eurheartj/ehae509. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39361488/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241005021335&v=2.18.0.post9+e462414">39361488</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae509>10.1093/eurheartj/ehae509</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39361488</guid>
<pubDate>Thu, 03 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Nicole M Warrington</dc:creator>
<dc:creator>Geng Wang</dc:creator>
<dc:creator>Tom A Bond</dc:creator>
<dc:date>2024-10-03</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Is lower birthweight truly causal for increased cardiovascular risk?</dc:title>
<dc:identifier>pmid:39361488</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae509</dc:identifier>
</item>
<item>
<title>Genetic analyses of birthweight and cardiovascular disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39361475/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241005021335&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 3:ehae510. doi: 10.1093/eurheartj/ehae510. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39361475/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241005021335&v=2.18.0.post9+e462414">39361475</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae510>10.1093/eurheartj/ehae510</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39361475</guid>
<pubDate>Thu, 03 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Maddalena Ardissino</dc:creator>
<dc:creator>Stephen Burgess</dc:creator>
<dc:creator>Fu Siong Ng</dc:creator>
<dc:date>2024-10-03</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Genetic analyses of birthweight and cardiovascular disease</dc:title>
<dc:identifier>pmid:39361475</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae510</dc:identifier>
</item>
<item>
<title>Weekly Journal Scan: Risk factors for recurrent ischaemic stroke in patients with atrial fibrillation on oral anticoagulation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39361473/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241005021335&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 3:ehae630. doi: 10.1093/eurheartj/ehae630. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39361473/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241005021335&v=2.18.0.post9+e462414">39361473</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae630>10.1093/eurheartj/ehae630</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39361473</guid>
<pubDate>Thu, 03 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Leonarda Galiuto</dc:creator>
<dc:creator>Carlo Patrono</dc:creator>
<dc:date>2024-10-03</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Weekly Journal Scan: Risk factors for recurrent ischaemic stroke in patients with atrial fibrillation on oral anticoagulation</dc:title>
<dc:identifier>pmid:39361473</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae630</dc:identifier>
</item>
<item>
<title>Reply: Early-Career Interventionalists: Hope for the Future and Opportunity for Change</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39357949/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241005021335&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Oct 8;84(15):e241. doi: 10.1016/j.jacc.2024.07.039.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39357949/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241005021335&v=2.18.0.post9+e462414">39357949</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.07.039>10.1016/j.jacc.2024.07.039</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39357949</guid>
<pubDate>Wed, 02 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Jennifer A Rymer</dc:creator>
<dc:creator>Dennis I Narcisse</dc:creator>
<dc:creator>W Schuyler Jones</dc:creator>
<dc:creator>Sunil V Rao</dc:creator>
<dc:creator>Jacob A Doll</dc:creator>
<dc:date>2024-10-02</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Reply: Early-Career Interventionalists: Hope for the Future and Opportunity for Change</dc:title>
<dc:identifier>pmid:39357949</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.07.039</dc:identifier>
</item>
<item>
<title>Early-Career Interventionalists: Hope for the Future and Opportunity for Change</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39357948/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241005021335&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Oct 8;84(15):e239-e240. doi: 10.1016/j.jacc.2024.06.047.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39357948/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241005021335&v=2.18.0.post9+e462414">39357948</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.06.047>10.1016/j.jacc.2024.06.047</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39357948</guid>
<pubDate>Wed, 02 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Jarrod D Frizzell</dc:creator>
<dc:creator>Lindsey Cilia</dc:creator>
<dc:creator>Kathryn L Dawson</dc:creator>
<dc:creator>Brett L Wanamaker</dc:creator>
<dc:creator>Rhian E Davies</dc:creator>
<dc:date>2024-10-02</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Early-Career Interventionalists: Hope for the Future and Opportunity for Change</dc:title>
<dc:identifier>pmid:39357948</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.06.047</dc:identifier>
</item>
<item>
<title>Are Apolipoprotein A1 Infusions Effective Without LDL Cholesterol Control?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39357947/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241005021335&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Oct 8;84(15):e237. doi: 10.1016/j.jacc.2024.05.083.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39357947/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241005021335&v=2.18.0.post9+e462414">39357947</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.05.083>10.1016/j.jacc.2024.05.083</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39357947</guid>
<pubDate>Wed, 02 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Francisco Blanco-Vaca</dc:creator>
<dc:creator>Joan Carles Escolà-Gil</dc:creator>
<dc:date>2024-10-02</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Are Apolipoprotein A1 Infusions Effective Without LDL Cholesterol Control?</dc:title>
<dc:identifier>pmid:39357947</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.05.083</dc:identifier>
</item>
<item>
<title>Reply: Patients With Cardiac Amyloidosis Are More Prone to Hypotension</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39357946/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241005021335&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Oct 8;84(15):e235. doi: 10.1016/j.jacc.2024.07.040.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39357946/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241005021335&v=2.18.0.post9+e462414">39357946</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.07.040>10.1016/j.jacc.2024.07.040</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39357946</guid>
<pubDate>Wed, 02 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Alberto Foà</dc:creator>
<dc:creator>Muthiah Vaduganathan</dc:creator>
<dc:creator>Scott D Solomon</dc:creator>
<dc:date>2024-10-02</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Reply: Patients With Cardiac Amyloidosis Are More Prone to Hypotension</dc:title>
<dc:identifier>pmid:39357946</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.07.040</dc:identifier>
</item>





























</channel>
</rss>